Infosys’ Salil Parekh In Line To Get Stock Incentives Worth Rs 10 Crore
Infosys Ltd. is planning to give incentives worth Rs 10 crore to its Chief Executive Officer Salil Parekh as part of its annual stock ownership programme for employees.
The board of the software services provider has approved granting restricted stock units to Parekh to “incentivise him to increase shareholder value and to drive execution excellence of the agreed business strategy”, the company said in an exchange filing. The stocks will be vested 12 months from the date of the grant.
Parekh's terms of appointment, too, have been tweaked by changing the vesting period of the annual equity grant to one year from three years earlier.
Parekh, who joined from Capgemini last year, has steadied the rocking ship and improved client confidence in India's second-largest software services provider. Despite headwinds to operating margin from currency fluctuation, higher cost and global uncertainties, Infosys reported steady revenue growth and strong client additions in the previous financial year.
The chief executive officer, when appointed in January 2018, was to draw an annual salary of up to Rs 18.6 crore, including the variable component.
Chief Operating Officer and Whole-Time Director UB Praving Rao has also been awarded restricted stock units worth Rs 4 crore.
Besides, Infosys expanded its stock ownership programme and the board has proposed to allocate 5 crore shares, about 1.15 percent of the company's equity, to a broad base of employees which will be linked to their performance.
“Our employees are our biggest asset, and through this programme we aim to recognise and reward individuals who are committed to driving value creation for all stakeholders through their continued and consistent performance,” Parekh said in the media statement. “By making employees owners, they get an opportunity to be beneficiaries in the long-term success of the company and realise the results of their work and dedication.”
The proposals are subject to shareholders' approval.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
